Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions
NCT04467190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 425
Last updated 2023-04-07
Summary
People with lung conditions can suffer significantly with their symptoms and often require multiple trips to their GP or secondary care before a diagnosis is made. It can be difficult to diagnose lung disease and to differentiate between different lung conditions, so many people may be misdiagnosed or incorrectly not given a diagnosis. The tests currently used to diagnose lung diseases can be difficult or uncomfortable to do, especially if the person is experiencing lots of symptoms, and therefore can give poor or unreliable results.A new quick and easy to perform test is needed that can differentiate between various lung conditions and people with no lung disease, that can be performed in primary and secondary care with immediate results.
Conditions
- Respiratory Disease
Sponsors & Collaborators
-
Portsmouth Hospitals NHS Trust
lead OTHER_GOV
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-13
- Primary Completion
- 2022-10-13
- Completion
- 2022-10-13
Countries
- United Kingdom
Study Locations
More Related Trials
-
EXhaled Hydrogen Peroxide As a Marker of Lung Disease Study - Conformité Européenne (European Conformity)
NCT04531449 ·Status: COMPLETED
-
Exhaled Breath Condensate (EBC) Assessment in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
NCT00448500 ·Status: COMPLETED
-
Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient
NCT03672994 ·Status: COMPLETED
-
Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma
NCT02703467 ·Status: COMPLETED
-
A Pilot Study to Characterise Saliva and Sputum FTIR Spectral Profiles in Patients with COPD During Exacerbations and When Stable
NCT04524819 ·Status: TERMINATED
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Assessment of an Exhaled Breath Test to Detect Bronchiectasis
NCT05293314 ·Status: COMPLETED
-
Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19
NCT04716023 ·Status: UNKNOWN
-
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
NCT06775106 ·Status: RECRUITING
-
Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis
NCT01410422 ·Status: UNKNOWN
-
Cough Frequency in Chronic Obstructive Pulmonary Disease
NCT01405222 ·Status: COMPLETED
-
Asthma Breath Biomarker Assessment
NCT03084016 ·Status: COMPLETED
-
COPD in the Time of COVID-19
NCT04407598 ·Status: UNKNOWN
-
Infectious Etiology of Acute Exacerbations of COPD
NCT00441389 ·Status: COMPLETED
-
Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis
NCT03643263 ·Status: COMPLETED
-
Functional Respiratory Imaging in Bronchiectasis
NCT03818646 ·Status: UNKNOWN
-
Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry
NCT01345266 ·Status: COMPLETED ·Phase: PHASE1
-
Change in Airway Peripheral Tone in COPD
NCT04166812 ·Status: UNKNOWN
-
Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations
NCT05704881 ·Status: RECRUITING
-
Optimization of Exhaled Biomarker Collection and Analysis
NCT05322785 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Respiratory Pathogens of Patients With Asthma and COPD Exacerbations
NCT02866357 ·Status: COMPLETED
-
Cough Monitoring in COPD
NCT07098793 ·Status: COMPLETED
-
Hydrogen Sulfide and Pulmonary Vascular Remodeling on HRCT in Patients With COPD
NCT04952883 ·Status: COMPLETED
-
The London COPD Exacerbation Cohort
NCT02755974 ·Status: RECRUITING
-
Airway Smooth Muscle and Asthma Severity
NCT00779870 ·Status: COMPLETED